Pharma has only itself to largely blame for nudging things towards price-setting legislation in the US, according to a former US government official.
Addressing the recent Indegene Digital Summit 2023, David Shulkin, former Secretary of the US Department of Veterans Affairs in the Trump Administration, stated that pharma’s relative inflexibility on pricing models was to blame for the Inflation Reduction Act (IRA) and the ripple effects of the legislation
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?